BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors
On Wednesday, BioAffinity Technologies Inc. (NASDAQ:BIAF) announced that the US Patent and Trademark Office/USPTO has issued a new patent.
Bioaffinity Technologies Inc. (BIAF)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 242,757 | $718,561 | 0.83% | |
| 2. | Scientech Research Le Duan | 16,583 | $49,086 | 0.02% | |
| 3. | 30,584 | $13,151 | +2736% | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Sprott Asset Management Eric Sprott | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 8,163 | $0.00 | 22,448 | 2022-08-31 | Filing | |
| $0.00 | 4,081 | $0.00 | 4,081 | 2022-08-31 | Filing | |
| $0.00 | 4,081 | $0.00 | 4,081 | 2022-08-31 | Filing | |
| $0.00 | 2,448 | $0.00 | 30,323 | 2022-09-01 | Filing | |
| $0.00 | 16,326 | $0.00 | 19,897 | 2022-08-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,429 | $30,870 | 0% | |
| 2. | 55,320 | $18,256 | 0% | |
| 3. | 47,669 | $15,731 | 0% | |
| 4. | 2,499 | $7,397 | 0% | |
| 5. | 1,791 | $5,302 | 0% |
News See All
Hedge Fund Resource Center Billionaire Hedge Funds
